|
Jun 5
|
Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal
|
|
Jun 5
|
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)
|
|
May 13
|
The Zacks Analyst Blog Highlights Amgen, Amazon.com, Apple, Boeing and Goldman Sachs
|
|
May 12
|
Amgen Is Working On a Wegovy Competitor -- What It Means for Investors
|
|
May 11
|
We Wouldn't Be Too Quick To Buy Amgen Inc. (NASDAQ:AMGN) Before It Goes Ex-Dividend
|
|
May 10
|
5 Stocks Driving Dow's Market-Beating Performance
|
|
May 9
|
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
|
|
May 9
|
Q1 2024 CytomX Therapeutics Inc Earnings Call
|
|
May 9
|
Sector Superstars: 3 Stocks Generating the Most Buzz on Wall Street
|
|
May 7
|
3 Tried and True Dividend Stocks to Buy for Your Portfolio
|
|
May 7
|
15 Best S&P 500 Dividend Stocks To Buy Now
|
|
May 6
|
Investors Pile Into Amgen in Search of Next Obesity Drug Payout
|
|
May 4
|
Amgen First Quarter 2024 Earnings: EPS Misses Expectations
|
|
May 4
|
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
|
|
May 3
|
Why Amgen Stock Zoomed Nearly 12% Higher Today
|
|
May 3
|
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
|
|
May 3
|
These Stocks Are Moving the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More
|
|
May 3
|
Analyst unveils Amgen stock price target after weight-loss drug data
|
|
May 3
|
Interest rate cuts could switch ‘from stroll to a sprint’ after US jobs surprise
|
|
May 3
|
Stocks to Watch Friday: Amgen, Apple, Exxon
|